Genetic Technologies Ltd has released a press release.
GeneType Outperforms Traditional Risk Assessments
Filed with ASX ·
6ix hasn’t read this filing yet.
Genetic Technologies Limited on 6ix
Earlier from Genetic Technologies
- GTG Building Momentum on Commercial Plans
- Annual Report to Shareholders and Appendix 4E
- Q4 FY22 Results Milestones and Growth
- GeneType Risk Test Implemented in 9 Siles Health Clinics
- Completion of AffinityDNA Acquisition
Later from Genetic Technologies
- Genetype for Ovarian Cancer published in European Journal
- AGM Presentation and Chairmans Address
- GeneType Published in PLUS ONE for CVD & Type 2 Diabetes
- Colorectal Cancer Model Presented at ASCOGI Cancer Symposium
- Appendix 4C and Quarterly Business Update December 2022
Follow Genetic Technologies into a list and get an email when it puts out news.
Follow Genetic Technologies